Twist Bioscience is enjoying a stock lift after announcing the settlement of a trade secret lawsuit filed by Agilent Technologies. Investors may feel more confident in Twist’s prospects in silicon-based DNA manufacturing - a big component of the synthetic biology industry.
from Forbes Real Time https://ift.tt/2w050OU
No comments:
Post a Comment